logo

For the Inventor, By the Inventor

Macclesfield, United Kingdom

Elwyn Peter Davies

This inventor holds 8 USPTO granted patents. Top assignee: Zeneca Limited. Active years: 1997-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elwyn Peter Davies. Retrieved from https://idiyas.com/inventor/elwyn-peter-davies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:

goldMedal8 out of 854 
 
Zeneca Limited
 patents

Years Active: 1997-2000

Loading Chart...
8 patents (USPTO):Explore Patents
1. 6054593 - Proline derivatives (2000-04-25),
2. 6048889 - Proline derivatives (2000-04-11),
3. 6037363 - Diastereomeric pure trifluoromethyl ketone peptide derivatives as (2000-03-14),
4. 5907043 - Diastereomeric pure trifluoromethyl ketone peptide derivatives as (1999-05-25),
5. 5861516 - Process for preparing an antifungal azole with hydrazino and amidrazone (1999-01-19),
6. 5808097 - Proline derivatives (1998-09-15),
7. 5739157 - Diastereomeric pure trifluoromethyl ketone peptide derivatives as (1998-04-14),
8. 5686628 - Proline derivatives (1997-11-11),

Title: Elwyn Peter Davies: Innovator in Pharmaceutical Chemistry

Introduction

Elwyn Peter Davies is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on proline derivatives. With a total of 8 patents to his name, Davies has established himself as a key figure in the development of therapeutic agents.

Latest Patents

Davies' latest patents focus on novel 1-substituted-N-[2-methyl-1-(trifluoroacetyl)propyl]pyrrolidine-2-carboxamide compounds. These compounds serve as inhibitors of human leukocyte elastase (HLE), also known as human neutrophil elastase (HNE). The inhibition of HLE is crucial for various research applications in pharmacology and diagnostics, as well as in the treatment of diseases where HLE is implicated. His inventions also encompass pharmaceutical compositions containing these forms, along with processes for their preparation and intermediates useful in their synthesis.

Career Highlights

Elwyn Peter Davies is associated with Zeneca Limited, where he has contributed to groundbreaking research and development in the pharmaceutical sector. His work has not only advanced scientific understanding but has also paved the way for new therapeutic options.

Collaborations

Davies has collaborated with notable colleagues, including Chris Allan Veale and Peter R Bernstein. These partnerships have enhanced the scope and impact of his research endeavors.

Conclusion

Elwyn Peter Davies is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the treatment of diseases. His innovative patents and collaborations continue to influence the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…